Learn More About Our Oncology Expertise
Mastering Oncology Immunotherapy Clinical Trials
For your convenience, our white papers, overviews and fact sheets can be accessed here.
Utilizing Investigational Technologies in Oncology Trials New technologies are changing oncology research – not only for cancer researchers but for patients. This paper explores the potential of liquid biopsies across diagnostics, therapy monitoring and disease recurrence from a clinical development … Read More
Supporting Your Complex Immunotherapy Trials. Our experienced project teams and custom approach to serving biopharma companies enable us to support the complex nature of immunotherapy trials from first-in-human trials to registration.
Harnessing Gene-Editing Technology for Oncology Trials The gene-editing technology has captured the attention of the life science and investment communities not only as an elegant tool in the classical science sense — simple and precise — but also as efficient and easy … Read More
Enrollment projections are critically important to biopharma companies with limited resources. Learn more about our methodology behind strategic patient enrollment.
Novella Clinical’s rapid start-up and enrollment sets the course for successful execution of this Phase II prostate cancer drug trial.
Novella Clinical delivers speedy database lock resulting in FDA approval three months ahead of schedule for a prostate cancer drug.
Novella’s creative approach speeds site initiation and database build in this Phase I, multi-center study.
Small Biotechs Know They Only Have One Shot at Developing Immunotherapies The reality of leveraging a patient’s immune system to disrupt cancer through immunotherapy is compelling. Standards of care are shifting, and drug developers are eager to leverage new technologies. … Read More
Investigating Candidate Treatments for Blood Cancers Today, conducting good clinical trials in hematological malignancies requires an understanding of a rapidly evolving treatment paradigm that is increasingly nuanced, complex and patient-directed. Sponsors developing hematological oncology therapies must capitalize on the principles … Read More
Explore Factors Most Critical to the Success of Late Phase Oncology Trials Many pharmaceutical, biotechnology and medical device companies have adopted globalization as a business model for their clinical trials. This model is especially pertinent within oncology with the number … Read More
Re-Imagine Oncology Data Management Clinical trial data technology (specifically electronic data capture, remote data review and advanced data visualization) combined with risk-based approaches to clinical monitoring presents sponsors, CROs and research sites with the opportunity to rethink traditional data management, … Read More
Driving Down Early Phase Oncology Protocol Amendments Oncology product development continues to dominate the global therapeutics market. This strength depends not only on continued use of existing products but also on the clinical and regulatory success of candidates now under … Read More
Helping You Improve the Lives of People With Cancer. Our dedicated Oncology Division has the global experience, knowledgeable staff and robust infrastructure to support our customers from Phase I through approval. Learn more from this oncology overview about our early and late … Read More
Dedicated Expertise in Your Fight Against Blood Cancers. Novella has dedicated hematology / oncology teams and processes to support hematologic studies. Learn more about our experience conducting clinical trials in hematologic malignancies.
Specialists Ready to Advance Your Next Genitourinary Trial. Genitourinary (prostate, renal and bladder) oncology is one of Novella’s largest areas of focus. Learn more about our experience with active GU studies around the world.
Understanding Companion Diagnostics Development The need for personalized medicine has successfully brought together and fully integrated the previously separate activities of drug and in vitro diagnostic (IVD) device development. This white paper outlines the necessary considerations for companion diagnostic test … Read More
Effective Strategies in Identifying, Enrolling and Retaining Patients Patients are essential to the development and approval of new oncology therapies, but the accrual and retention of oncology clinical trial participants present nuanced and complicated challenges. This white paper moves beyond … Read More